Sort
39,280 grants matching “leukemia”
Gene and Cytokine Expression in Tolerance and GVHD
$396,000Minnie M Sarwal · Stanford University · R01 · FY2010 · AI
Nanowaveguide Illuminated Fluorescence Spectroscopy for Studying Membrane Protein Dynamics
$396,000Zhe-Sheng Chen · St. John'S University · R15 · FY2015 · GM
Genetic regulation of hematopoietic stem cells
$396,000Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2012 · HL
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
$396,000William E. Evans · St. Jude Children'S Research Hospital · R37 · FY2008 · CA
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
$395,996Scott A Armstrong · Dana-Farber Cancer Inst · R01 · FY2022 · CA
The paradox of myeloid leukemia of Down syndrome
$395,973Jeffrey W Taub · Wayne State University · R21 · FY2023 · CA
Regulation of hematopoietic stem cells and leukemia stem cells by thrombopoietin
$395,968Lei Ding · Columbia University Health Sciences · R01 · FY2018 · HL
Regulation of hematopoietic stem cells and leukemia stem cells by thrombopoietin
$395,962Lei Ding · Columbia University Health Sciences · R01 · FY2019 · HL
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
$395,946Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
ABL ONCOGENE AND MURINE AND HUMAN LEUKEMIAS
$395,938University Of California Los Angeles · R01 · FY2000 · CA
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
$395,932Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Fanconi Anemia: Genotype-Phenotype Correlations
$395,925Settara Chandrasekharappa · National Human Genome Research Institute · ZIA · FY2025 · HG
Intracellular Signaling in Malignant Lymphoma Cells
$395,892Garry P Nolan · Stanford University · P01 · FY2009 · CA
Targeting Microenvironmental Signals in Myeloid Malignancies
$395,869Jeevisha Bajaj · University Of Rochester · R01 · FY2022 · CA
Molecular Analysis of Del(9q) Acute Myeloid Leukemia
$395,847David A Sweetser · Massachusetts General Hospital · R01 · FY2008 · CA
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia
$395,809Kevin M Shannon · Indiana University Indianapolis · U54 · FY2019 · CA
Improve the engraftment of combinatorial anti-HIV-1 gene modified HSPC
$395,756Dong Sung An · University Of California Los Angeles · U19 · FY2015 · AI
Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia
$395,738Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R37 · FY2019 · CA
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
$395,738Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
FANCM in repair of stalled replication forks
$395,738Ralph Scully · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA
Role of BAZ2A in MLL-r leukemia and therapeutic response
$395,738Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia
$395,738Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R37 · FY2021 · CA
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
$395,738Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Role of BAZ2A in MLL-r leukemia and therapeutic response
$395,738Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
FANCM in repair of stalled replication forks
$395,738Ralph Scully · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA